Ethema Health Revenue Growth Rates (GRST), Current and Historic Growth - CSIMarket
CSIMarket
 


Ethema Health Corporation   (GRST)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

GRST's Revenue Growth by Quarter and Year

Ethema Health 's Revenue results by quarter and year




GRST Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 4.81
3rd Quarter September 5.53
2nd Quarter June 4.91
1st Quarter March 3.52
FY 18.77

GRSTs Annual Revenue
Ethema Health 's Revenue in the fiscal year 2025 $ 18.76 millions
Ethema Health 's Revenue in the fiscal year 2024 $ 6.02 millions
Ethema Health 's Revenue in the fiscal year 2023 $ 5.34 millions
Ethema Health 's Revenue in the fiscal year 2022 $ 4.82 millions
Ethema Health 's Revenue in the fiscal year 2021 $ 1.94 millions




GRST Revenue fourth quarter 2024 Y/Y Growth Comment
Ethema Health Corporation achieved in the fourth quarter 2024, above Company average Revenue surge of 227.36% year on year, to $ 4.81 millions.

Looking into fourth quarter 2024 results within Healthcare Facilities industry 21 other companies have achieved higher Revenue growth. While Ethema Health Corporation ' s Revenue doubling of 227.36% ranks overall at the positon no. 1773 in the fourth quarter 2024.




GRST Revenue ( Y/Y Growth %) 2024
2023 2022 2021
4th Quarter December 227.36 % 30.09 % -8.13 % 38.2 %
3rd Quarter September 214.2 % 30.37 % -4.93 % 63.22 %
2nd Quarter June 229.53 % -5.1 % 37.72 % 1040 %
1st Quarter March 170.77 % 0 % 27.45 % 1033.33 %
FY   211.83 % 12.52 % 11.23 % -

Financial Statements
Ethema Health 's fourth quarter 2024 Revenue $ 4.81 millions GRST's Income Statement
Ethema Health 's fourth quarter 2023 Revenue $ 1.47 millions Quarterly GRST's Income Statement


GRST Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
4th Quarter December -12.98 % -16.48 % -16.3 % -13.38 %
3rd Quarter September 12.63 % 18.12 % -14.01 % 24.56 %
2nd Quarter June 39.49 % 14.62 % 20.77 % 11.76 %
1st Quarter March 139.46 % 15.04 % 5.69 % 14.61 %
FY (Year on Year)   211.83 % 12.52 % 11.23 % -




Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #22
Healthcare Sector #285
Overall #1773

Revenue Y/Y Growth Statistics
High Average Low
4495.68 % 171.37 % -143.25 %
(Sep 30 2019)   (Sep 30 2017)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #22
Healthcare Sector #285
Overall #1773
Revenue Y/Y Growth Statistics
High Average Low
4495.68 % 171.37 % -143.25 %
(Sep 30 2019)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Ethema Health 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
801.05 % 35.54 % -78.58 %
(Sep 30 2021)  


GRST's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2024 Ethema Health Corporation disclosed drop in Revenue from the third quarter by -12.98% to $ 4.81 millions, from $ 5.53 millions achived in the previous reporting period.

But that's not important problem, as Ethema Health 's Revenue generally seem to plunge in this quarter.

Within Healthcare Facilities industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Ethema Health 's Revenue growth quarter on quarter, overall rank is 3588.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #41
Healthcare Sector #493
Overall #3588
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #41
Healthcare Sector #493
Overall #3588
Revenue Q/Q Growth Statistics
High Average Low
801.05 % 35.54 % -78.58 %
(Sep 30 2021)  


GRST's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2024 Ethema Health Corporation disclosed drop in Revenue from the third quarter by -12.98% to $ 4.81 millions, from $ 5.53 millions achived in the previous reporting period.

But that's not important problem, as Ethema Health 's Revenue generally seem to plunge in this quarter.

Within Healthcare Facilities industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Ethema Health 's Revenue growth quarter on quarter, overall rank is 3588.


Ethema Health 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
12 Months Ending
(Dec 31 2024)
Cumulative Revenue 12 Months Ending $ 18.76 $ 15.42 $ 11.65 $ 8.23 $ 6.02
Y / Y Revenue Growth (TTM) 211.85 % 171.7 % 121.1 % 54.07 % 12.58 %
Year on Year Revenue Growth Overall Ranking # 1154 # 1816 # 2451 # 0 # 1101
Seqeuential Revenue Change (TTM) 21.69 % 32.35 % 41.47 % 36.86 % 6.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 1773 # 1410 # 2243 # 0 # 2442


Cumulative Revenue growth Comment
Ethema Health saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 211.85% year on year, to $ 19 millions if the fiscal year would have ended in Dec 31 2025.
Ethema Health 's trailing twelve months Revenue growth was higher than company's average 171.37% and higher than 171.7% growth in Sep 30 2025.
But from twelve months ended Sep 30 2025 rise was beneth at 21.69 % from $15.42 millions achieved in the period from Sep 30 2025 to Dec 31 2024.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at171.37%.
The momentum is even more impressive from twelve months ended Sep 30 2025 exhibited at 21.69 % increase from $15.42 millions in the period from Sep 30 2025 to Dec 31 2024.

In the Healthcare sector 217 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1154, from total ranking in previous quarter at 1816.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 22
Healthcare Sector # 218
Overall # 1154

Revenue TTM Y/Y Growth Statistics
High Average Low
4495.68 %
171.37 %
-143.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 285
S&P 500 # 1773
Cumulative Revenue growth Comment
Ethema Health saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 211.85% year on year, to $ 19 millions if the fiscal year would have ended in Dec 31 2025.
Ethema Health 's trailing twelve months Revenue growth was higher than company's average 171.37% and higher than 171.7% growth in Sep 30 2025.
But from twelve months ended Sep 30 2025 rise was beneth at 21.69 % from $15.42 millions achieved in the period from Sep 30 2025 to Dec 31 2024.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at171.37%.
The momentum is even more impressive from twelve months ended Sep 30 2025 exhibited at 21.69 % increase from $15.42 millions in the period from Sep 30 2025 to Dec 31 2024.

In the Healthcare sector 217 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1154, from total ranking in previous quarter at 1816.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 22
Healthcare Sector # 218
Overall # 1154

Revenue TTM Y/Y Growth Statistics
High Average Low
4495.68 %
171.37 %
-143.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 285
S&P 500 # 1773




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GRST's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Aspira Women s Health inc 385.61%$ 385.609 millions
Intercure Ltd 318.38%$ 318.385 millions
Vireo Growth Inc.317.81%$ 317.813 millions
Cormedix Inc 312.10%$ 312.097 millions
Galapagos Nv303.50%$ 303.502 millions
Insmed Inc287.83%$ 287.825 millions
Tscan Therapeutics Inc 286.02%$ 286.015 millions
Beam Therapeutics Inc 279.52%$ 279.516 millions
Meiragtx Holdings Plc252.33%$ 252.333 millions
Star Equity Holdings Inc 232.22%$ 232.220 millions
Ethema Health Corporation 228.03%$ 228.030 millions
Foghorn Therapeutics Inc 223.77%$ 223.775 millions
Madrigal Pharmaceuticals Inc 210.77%$ 210.766 millions
Biocryst Pharmaceuticals Inc 209.09%$ 209.087 millions
Prenetics Global Limited201.94%$ 201.941 millions
Prokidney Corp 196.05%$ 196.053 millions
Mesoblast Limited191.39%$ 191.393 millions
Northwest Biotherapeutics Inc190.91%$ 190.909 millions
Zevra Therapeutics Inc 183.36%$ 183.360 millions
Spero Therapeutics Inc 174.51%$ 174.508 millions
Taysha Gene Therapies Inc 171.27%$ 171.266 millions
Compugen Ltd161.14%$ 161.140 millions
Nyxoah Sa156.29%$ 156.287 millions
Nuo Therapeutics Inc 153.57%$ 153.570 millions
Anaptysbio Inc 151.08%$ 151.082 millions
Theravance Biopharma inc 144.70%$ 144.700 millions
Voyager Therapeutics Inc 144.28%$ 144.282 millions
Esperion Therapeutics Inc 143.73%$ 143.725 millions
Foxo Technologies Inc 141.54%$ 141.542 millions
Volitionrx Limited133.25%$ 133.247 millions


About Ethema Health Revenue Growth Rates (GRST), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Ethema Health Corp (CIK 792935).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001903596-26-000271
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Ethema Health Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.